These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8707962)

  • 21. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
    Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K
    J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
    Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
    Bech E; Andersen H; Orntoft TF; Jakobsen J
    Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of anti-GM1 antibody positive HTLV-I associated myelopathy (HAM) with polyneuropathy].
    Yanagihara C; Ihara M; Nishimura Y; Oka N
    Rinsho Shinkeigaku; 1999 Sep; 39(9):971-5. PubMed ID: 10614165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model.
    Harschnitz O; van den Berg LH; Johansen LE; Jansen MD; Kling S; Vieira de Sá R; Vlam L; van Rheenen W; Karst H; Wierenga CJ; Pasterkamp RJ; van der Pol WL
    Ann Neurol; 2016 Jul; 80(1):71-88. PubMed ID: 27130524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptoms.
    Ala TA; Perfetti PA; Frey WH
    J Neuroimmunol; 1994 Aug; 53(1):109-13. PubMed ID: 8051293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of anti-GM1 IgM antibodies.
    Nobile-Orazio E; Carpo M; Scarlato G
    Acta Neurol (Napoli); 1991 Dec; 13(6):514-9. PubMed ID: 1805551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spectrum of neurologic disease associated with anti-GM1 antibodies.
    Sadiq SA; Thomas FP; Kilidireas K; Protopsaltis S; Hays AP; Lee KW; Romas SN; Kumar N; van den Berg L; Santoro M
    Neurology; 1990 Jul; 40(7):1067-72. PubMed ID: 2162499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
    J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1.
    Zielasek J; Ritter G; Magi S; Hartung HP; Toyka KV
    J Neurol; 1994 Jul; 241(8):475-80. PubMed ID: 7964915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-GM1 antibodies: the cause of otherwise unexplained ophthalmoplegias?
    Kowal L; Gajus MA; Kornberg AJ
    Clin Exp Ophthalmol; 2004 Aug; 32(4):411-4. PubMed ID: 15281977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM1 antibodies in post-polio syndrome and previous paralytic polio.
    Farbu E; Rekand T; Tysnes OB; Aarli JA; Gilhus NE; Vedeler CA
    J Neuroimmunol; 2003 Jun; 139(1-2):141-4. PubMed ID: 12799031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pediatric case of peripheral polyneuropathy with IgM anti-GM1 antibody associated with A group a beta-hemolytic Streptococcus infection.
    Ishikawa N; Kobayashi Y; Fujii Y; Samukawa M; Kusunoki S; Kobayashi M
    Pediatr Neurol; 2014 Sep; 51(3):441-3. PubMed ID: 25160552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.
    Campbell AW; Thrasher JD; Madison RA; Vojdani A; Gray MR; Johnson A
    Arch Environ Health; 2003 Aug; 58(8):464-74. PubMed ID: 15259425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiglycolipid antibodies in motor neuropathies.
    Baumann N; Harpin ML; Marie Y; Lemerle K; Chassande B; Bouche P; Meininger V; Yu RK; Léger JM
    Ann N Y Acad Sci; 1998 Jun; 845():322-9. PubMed ID: 9668365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.